Research Topics
| Joshua A SalomonSummaryAffiliation: Harvard University Country: USA Publications
| Collaborators
|
Detail Information
Publications
Healthy life expectancy for 187 countries, 1990-2010: a systematic analysis for the Global Burden Disease Study 2010Joshua A Salomon
Harvard School of Public Health, Harvard University, Boston, MA 02115, USA
Lancet 380:2144-62. 2012..These comparisons can inform policy questions that depend on how morbidity changes as mortality decreases. We characterise current HALE and changes over the past two decades in 187 countries...- Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010Joshua A Salomon
Harvard School of Public Health, MA, USA
Lancet 380:2129-43. 2012.... 
Intervention strategies to reduce the burden of non-communicable diseases in Mexico: cost effectiveness analysisJoshua A Salomon
Department of Global Health and Population, Harvard School of Public Health, 665 Huntington Avenue, Boston, MA 02115, USA
BMJ 344:e355. 2012..To inform decision making regarding intervention strategies against non-communicable diseases in Mexico, in the context of health reform...- Are Americans feeling less healthy? The puzzle of trends in self-rated healthJoshua A Salomon
Harvard University Initiative for Global Health, Cambridge, MA 02138, USA
Am J Epidemiol 170:343-51. 2009..More work is urgently needed on robust and comparable approaches to tracking population health... - Evaluating the impact of antiretroviral therapy on HIV transmissionJoshua A Salomon
Department of Population and International Health, Harvard School of Public Health, Boston, Massachusetts, USA
AIDS 22:S149-59. 2008.... - Comparability of patient-reported health status: multicountry analysis of EQ-5D responses in patients with type 2 diabetesJoshua A Salomon
Department of Global Health and Population, Harvard School of Public Health, Boston, MA 02115, USA
Med Care 49:962-70. 2011..Valid and comparable measures of health outcomes are needed for clinical trials, studies on quality of healthcare, and population health monitoring... - Prospects for advancing tuberculosis control efforts through novel therapiesJoshua A Salomon
Department of Population and International Health, Harvard School of Public Health, Boston, Massachusetts, United States of America
PLoS Med 3:e273. 2006..As new candidates emerge from the global TB drug pipeline, the potential impacts of novel, shorter regimens on TB incidence and mortality have not yet been examined... 
A multi-method approach to measuring health-state valuationsJoshua A Salomon
Evidence and Information for Policy, World Health Organization, Geneva, Switzerland
Health Econ 13:281-90. 2004....- Integrating HIV prevention and treatment: from slogans to impactJoshua A Salomon
Harvard Center for Population and Development Studies, Department of Population and International Health, Harvard School of Public Health, Boston, Massachusetts, USA
PLoS Med 2:e16. 2005..In this paper, we quantify the opportunities and potential risks of large-scale treatment roll-out... - Cost-effectiveness of treatment for chronic hepatitis C infection in an evolving patient populationJoshua A Salomon
Harvard Center for Population and Development Studies, Cambridge, Mass 02138, USA
JAMA 290:228-37. 2003..Approximately 2.7 million US individuals are chronically infected with the hepatitis C virus (HCV). As public health campaigns are pursued, a growing number of treatment candidates are likely to have minimal evidence of liver damage... - Taking account of future technology in cost effectiveness analysisJoshua A Salomon
Department of Population and International Health, Harvard School of Public Health, Harvard Center for Population and Development Studies, 9 Bow Street, Cambridge MA 02138, USA
BMJ 329:733-6. 2004 - Comparability of self rated health: cross sectional multi-country survey using anchoring vignettesJoshua A Salomon
Department of Population and International Health, Center for Population and Development Studies, Harvard School of Public Health, 9 Bow Street, Cambridge, MA 02138, USA
BMJ 328:258. 2004..To examine differences in expectations for health using anchoring vignettes, which describe fixed levels of health on dimensions such as mobility... - Global patterns of healthy life expectancy in the year 2002Colin D Mathers
Evidence and Information for Policy, World Health Organization, Avenue Appia, Geneva, Switzerland
BMC Public Health 4:66. 2004..The World Health Organization reports on healthy life expectancy for 192 WHO Member States. This paper describes variation in average levels of population health across these countries and by sex for the year 2002... - Cost-effectiveness of treating multidrug-resistant tuberculosisStephen C Resch
Department of Health Policy and Management, Harvard School of Public Health, Harvard University, Boston, Massachusetts, United States of America
PLoS Med 3:e241. 2006..We projected the health benefits and cost-effectiveness of using drug susceptibility testing and second-line drugs in a lower-middle-income setting with high levels of MDR TB... - Cost-effectiveness of treatment for hepatitis C in an urban cohort co-infected with HIVNicole G Campos
Program in Health Policy, Harvard University, Cambridge, Mass, USA
Am J Med 120:272-9. 2007..Our objective was to use these data to examine the cost-effectiveness of treating HCV in an urban cohort of co-infected patients... - Cost-effectiveness of Rotavirus vaccination in VietnamSun Young Kim
Department of Health Policy and Management, Harvard School of Public Health, Boston, MA, USA
BMC Public Health 9:29. 2009..g., the possibility of reinfection and varying degrees of partial immunity conferred by natural infection), and assess the influence of the features on the cost-effectiveness of rotavirus vaccination... - Healthy life expectancy: comparison of OECD countries in 2001Colin D Mathers
Global Program on Evidence for Health Policy, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland
Aust N Z J Public Health 27:5-11. 2003..To compare average levels of population health for Australia and other OECD countries in 2001... - National HIV prevalence estimates for sub-Saharan Africa: controlling selection bias with Heckman-type selection modelsDaniel R Hogan
Harvard School of Public Health, Department of Global Health and Population, 665 Huntington Ave, Building 1, Boston, MA 02115, USA
Sex Transm Infect 88:i17-23. 2012..We control for selection bias in national HIV prevalence estimates using a novel approach, which unlike conventional imputation can account for selection on unobserved factors... - Global patterns of healthy life expectancy for older womenColin D Mathers
Global Programme on Evidence for Health Policy, World Health Organization, Geneva, Switzerland
J Women Aging 14:99-117. 2002..We discuss the implications of the findings for international health policy... - Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16,18 vaccinationJeremy D Goldhaber-Fiebert
Doctoral Program in Health Policy, Decision Science Concentration, Harvard University, Cambridge, MA, USA
J Natl Cancer Inst 100:308-20. 2008.... - Household and community socioeconomic and environmental determinants of child nutritional status in CameroonRoland Pongou
Harvard School of Public Health, Boston, MA, USA
BMC Public Health 6:98. 2006..We further consider age-specific effects of household economic status on child nutrition... - Flexible epidemiological model for estimates and short-term projections in generalised HIV/AIDS epidemicsDaniel R Hogan
Center for Health Decision Science, Harvard School of Public Health, 718 Huntington Avenue, Boston, MA 02115, USA
Sex Transm Infect 86:ii84-92. 2010..Our objective was to develop modifications to the current model that improve fit to recently observed prevalence trends across countries... - Cost effectiveness analysis of strategies to combat HIV/AIDS in developing countriesDaniel R Hogan
Harvard Center for Population and Development Studies, Harvard School of Public Health, Cambridge, MA 02138, USA
BMJ 331:1431-7. 2005..Antiretroviral therapy is at least as cost effective in improving population health as some of these interventions... - Exploring model uncertainty in economic evaluation of health interventions: the example of rotavirus vaccination in VietnamSun Young Kim
Center for Health Decision Science, Harvard School of Public Health, Boston, MA, USA
Med Decis Making 30:E1-E28. 2010.... - Population health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluationNicolas A Menzies
Center for Health Decision Sciences, Harvard School of Public Health, Boston, Massachusetts, United States of America
PLoS Med 9:e1001347. 2012..As roll-out proceeds, it is essential to understand the potential health impact and cost-effectiveness of diagnostic strategies based on Xpert... - Effects of healthcare reforms on coverage, access, and disparities: quasi-experimental analysis of evidence from MassachusettsAakanksha H Pande
Department of Population Medicine, Harvard Medical School, Boston, Massachusetts 02215, USA
Am J Prev Med 41:1-8. 2011..The potential impact of national healthcare reform may be considered using a similar set of state-level reforms including exchanges and a mandate, enacted in 2006 in Massachusetts... - Empirically calibrated model of hepatitis C virus infection in the United StatesJoshua A Salomon
Global Programme on Evidence for Health Policy, World Health Organization, Geneva, Switzerland
Am J Epidemiol 156:761-73. 2002..These findings have important implications both for individual clinical decisions and for broader public health policy... - Economic evaluation of hepatitis B vaccination in low-income countries: using cost-effectiveness affordability curvesSun Young Kim
Program in Health Decision Science, Health Policy and Management Department, Harvard School of Public Health, Boston, MA 02115, USA
Bull World Health Organ 85:833-42. 2007..We sought to describe a method that explicitly considers both a health-care programmes cost-effectiveness and its affordability. For illustration, we apply the method to the programme to vaccinate infants against hepatitis B in the Gambia... - Cost effectiveness of alternative surveillance strategies for hepatocellular carcinoma in patients with cirrhosisKarin L Andersson
Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA
Clin Gastroenterol Hepatol 6:1418-24. 2008..We assessed the costs, clinical benefits, and cost effectiveness of US surveillance and alternative strategies for HCC in cirrhosis using a computer-based state transition model with parameters derived from available literature... - Modeling human papillomavirus and cervical cancer in the United States for analyses of screening and vaccinationJeremy D Goldhaber-Fiebert
Department of Health Policy and Management, Harvard School of Public Health, Boston, USA
Popul Health Metr 5:11. 2007..S. policy choices for cervical cancer prevention, we developed a model of human papillomavirus (HPV) and cervical cancer, explicitly incorporating uncertainty about the natural history of disease... - Evolution of antiretroviral drug costs in Brazil in the context of free and universal access to AIDS treatmentAmy S Nunn
Department of Population and International Health, Harvard School of Public Health, Boston, Massachusetts, United States of America
PLoS Med 4:e305. 2007..In this study, we investigate the drivers of recent ARV cost trends in Brazil through analysis of drug-specific prices and expenditures between 2001 and 2005... - Packaging health services when resources are limited: the example of a cervical cancer screening visitJane J Kim
Department of Health Policy and Management, Harvard School of Public Health, Boston, Massachusetts, United States of America
PLoS Med 3:e434. 2006.... - Assessing the population health impact of market interventions to improve access to antiretroviral treatmentTill Barnighausen
Department of Global Health and Population, Harvard School of Public Health, Boston, MA 02115, USA
Health Policy Plan 27:467-76. 2012..We offer seven recommendations for ex ante and ex post assessment of population health impact of market interventions... - Spline-based modelling of trends in the force of HIV infection, with application to the UNAIDS Estimation and Projection PackageDaniel R Hogan
Harvard School of Public Health, Department of Global Health and Population, 665 Huntington Ave, Boston, MA 02115, USA
Sex Transm Infect 88:i52-7. 2012..Here, we test the feasibility of this approach for concentrated HIV/AIDS epidemics with very sparse data and compare two methods for making short-term future projections with the spline-based model... - Non-monotonicity in the episodic random utility modelNicolas A Menzies
Center for Health Decision Sciences, Harvard University, Boston, MA, USA
Health Econ 20:1523-31. 2011..These results present some challenge to the use of the eRUM estimator in generating health-state valuations for population health measurement and economic evaluation... - Health impacts of macroeconomic crises and policies: determinants of variation in childhood malnutrition trends in CameroonRoland Pongou
Harvard School of Public Health, Boston, MA, USA
Int J Epidemiol 35:648-56. 2006..We examined the effects of economic crises and adjustment programmes during the 1990s in Cameroon on childhood malnutrition in population subgroups and evaluated the household and health system mediators of these effects... - Prevention and treatment of human immunodeficiency virus/acquired immunodeficiency syndrome in resource-limited settingsDaniel R Hogan
Harvard Center for Population and Development Studies, Harvard School of Public Health, 9 Bow Street, Cambridge, MA 02138, USA
Bull World Health Organ 83:135-43. 2005..Successful integration of treatment and prevention of HIV/AIDS will require a balanced approach and rigorous monitoring of the impact of programmes in terms of both individual and population outcomes... - Preferences for health outcomes associated with Group A Streptococcal disease and vaccinationGrace M Lee
Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, 133 Brookline Avenue, Boston, MA 02215, USA
Health Qual Life Outcomes 8:28. 2010..g. averted GAS disease vs. vaccine adverse events)... - Health-state valuations for pertussis: methods for valuing short-term health statesGrace M Lee
Center for Child Health Care Studies, Department of Ambulatory Care and Prevention, Harvard Pilgrim Health Care and Harvard Medical School, 133 Brookline Ave, 6th Floor, Boston, MA 02215, USA
Health Qual Life Outcomes 3:17. 2005..S. Our objectives were: (1) to describe patient valuations of pertussis disease and vaccination; and (2) to compare valuations for short-term and long-term health states associated with pertussis... - HIV treatment as prevention: issues in economic evaluationTill Barnighausen
Department of Global Health and Population, Harvard School of Public Health, Boston, Massachusetts, United States of America
PLoS Med 9:e1001263. 2012..Third, the preventive effects of TasP are likely to alter the composition of the HIV-infected population over time, changing its biological and behavioral characteristics and leading to different costs and outcomes for ART... - Illness transmission in the home: a possible role for alcohol-based hand gelsGrace M Lee
Center for Child Health Care Studies, Department of Ambulatory Care and Prevention, Harvard Pilgrim Health Care and Harvard Medical School, Boston, Massachusetts 02215, USA
Pediatrics 115:852-60. 2005..We also sought to examine potential predictors of reduced illness transmission in the home in a secondary analysis... - Can we reverse the HIV/AIDS pandemic with an expanded response?John Stover
Futures Group International, Glastonbury, CT, USA
Lancet 360:73-7. 2002..Analyses suggest that if the successes achieved in some countries in prevention of transmission can be expanded to a global scale by 2005, about 29 million new infections could be prevented by 2010... - The global impact of scaling up HIV/AIDS prevention programs in low- and middle-income countriesJohn Stover
Futures Group/Constella, Glastonbury, CT 06033, USA
Science 311:1474-6. 2006..Thus, greater spending on prevention now would not only prevent more than half the new infections that would occur from 2005 to 2015 but would actually produce a net financial saving as future costs for treatment and care are averted... - Impact of HIV on novel therapies for tuberculosis controlMaria S Sanchez
Department of Environmental Science, Policy and Management, University of California, Berkeley, California 94720 3114, USA
AIDS 22:963-72. 2008..We investigated how tuberculosis is impacted by reducing treatment duration alone or combined with enhanced case detection and/or cure under different HIV prevalence levels... - Priority setting for health interventions in Mexico's System of Social Protection in HealthEduardo Gonzalez-Pier
Mexican Ministry of Health, Mexico City, Mexico
Lancet 368:1608-18. 2006.... - [Priority setting for health interventions in Mexico's System of Social Protection in Health]Eduardo Gonzalez-Pier
Unidad de Análisis Económico, Secretaria de Salud, Mexico, Paseo de la Reforma 450, PH, Col Juárez, 06600 Mexico, DF, Mexico
Salud Publica Mex 49:S37-52. 2007.... - Quantification of health states with rank-based nonmetric multidimensional scalingPaul F M Krabbe
Department of Medical Technology Assessment 138, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
Med Decis Making 27:395-405. 2007..This methodology is based on the ranking of differences between health states combined with an associated scaling model that transforms the individual rank data into group values on the interval level... - Estimating the net effect of HIV on child mortality in African populations affected by generalized HIV epidemicsMilly Marston
London School of Hygiene and Tropical Medicine, London, United Kingdom
J Acquir Immune Defic Syndr 38:219-27. 2005..The curve also predicts 13% net survival at 10 years using constraints based on survival of infected adults... - Enlightened self-interest and the control of tuberculosisBarry R Bloom
N Engl J Med 353:1057-9. 2005 - Global burden of disease 2005: call for collaboratorsChristopher J L Murray
Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA 98104, USA
Lancet 370:109-10. 2007